Nitrome Biosciences
Jackson, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
ZH
Zach HallDirector
EH
Ephraim HellerDirector
WM
William McDowellDirector
IG
Irene Griswold-PrennerExecutive Officer, Director
RK
Regis KellyDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$17.1MraisedApr 2020 · 18 investors · BiotechnologyRule 506(b)
▶$17.1MraisedApr 2020 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Margarita ChavezDirector
- Irene Griswold-PrennerExecutive Officer, Director
- Henrijette RichterDirector
- Jonathan BehrDirector
- Offering amount
- $47.5M
- Amount sold
- $17.1M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedJul 2019 · 9 investors · BiotechnologyRule 506(b)
▶$500KraisedJul 2019 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zach HallDirector
- Ephraim HellerDirector
- William McDowellDirector
- Irene Griswold-PrennerExecutive Officer, Director
- Regis KellyDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$400KraisedJan 2019 · 8 investors · BiotechnologyRule 506(b)
▶$400KraisedJan 2019 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Regis KellyDirector
- Irene Griswold-PrennerExecutive Officer, Director
- Zach W. HallDirector
- William McDowellDirector
- Ephraim HellerDirector
- Offering amount
- $1.6M
- Amount sold
- $400K
- Minimum investment
- $10K
- Proceeds to insiders
- $14.5K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedJul 2018 · 5 investors · BiotechnologyRule 506(b)
▶$750KraisedJul 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Irene Griswold-PrennerExecutive Officer
- Offering amount
- $2.4M
- Amount sold
- $750K
- Minimum investment
- $10K
- Proceeds to insiders
- $250K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$104.6KraisedJul 2018 · 5 investors · BiotechnologyRule 506(b)
▶$104.6KraisedJul 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Regis KellyDirector
- Ephreim HellerDirector
- Zach W. HallDirector
- Irene Griswold-PrennerExecutive Officer, Director
- Offering amount
- $104.6K
- Amount sold
- $104.6K
- Minimum investment
- $900
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.